Case involving senior dosimetrist at a premier cancer hospital in the Northeast suggests potential relevance of Phyto-N in one of oncology’s most serious and underserved supportive-care markets The ...
A jury awarded $42.4 million to the estate of a patient who died after staff failed to get the patient’s baclofen prescription filled in a timely manner, a case study posted on the American Pharmacy ...
Investor's Business Daily on MSN
Abivax hits 'best-case' scenario for ulcerative colitis drug; so, why did shares plummet?
Abivax stock crashed Monday after several patients developed cancer following a study of its ulcerative colitis treatment.
SAN DIEGO, Sept. 25, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor therapies, ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released ...
Adverse drug effects commonly occur in patients with rheumatologic diseases, most of whom take multiple medications to ...
Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — The case of a 29-year-old woman with chronic kidney disease presented at ASN Kidney Week ...
CyPath® Lung test affirmed physician’s assessment that the nodule could be inflammation, not cancer; nodule resolved upon follow-up scan Noninvasive CyPath® Lung performed with 92% sensitivity, 87% ...
Researchers at Harvard Medical School found that a new open-source artificial intelligence tool is diagnosing patients as accurately as leading proprietary models — like OpenAI’s GPT-4 — for the first ...
A single-patient case study raises concerns about the carnivore diet’s impact on kidney stone risk—does cutting out plants do more harm than good? Case Study: You are what you eat—should it be all ...
Gregory DeLassus, Aydin Harston Ph.D. The U.S. Court of Appeals for the Federal Circuit recently issued a non-precedential Rule 36 affirmance of the Patent Trial and Appeal Board (PTAB) in In re Adhami ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results